Janney Montgomery Scott
TLIS

Janney Montgomery Scott’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Janney Montgomery Scott’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-667
Closed -$62K – 2443
2021
Q3 		$62K Hold
667
– – ﹤0.01% 2271
2021
Q2 		$110K Hold
667
– – ﹤0.01% 2203
2021
Q1 		$128K Buy
+667
New +$166K ﹤0.01% 2112

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janney Montgomery Scott's TLIS Position: Q4 2021 in Review

Janney Montgomery Scott sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q4 2021, closing a stake of 667 shares — an estimated $62K sold.

Janney Montgomery Scott first reported a position in TLIS in Q1 2021 and held it in 3 quarters. The position peaked at $128K in Q1 2021. 46 funds tracked by Wall St. Rank hold TLIS as of Q4 2021.

  • Janney Montgomery Scott reported no remaining Talis Biomedical Corporation Common Stock position as of Q4 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 667 Talis Biomedical Corporation Common Stock shares in Q4 2021, an estimated $62K.
  • Janney Montgomery Scott first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 3 quarters.
  • Janney Montgomery Scott's Talis Biomedical Corporation Common Stock position peaked at $128K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q4 2021.

Based on Janney Montgomery Scott's 13F filing for Q4 2021, filed 27 Jan 2022.